As for data at baseline, we then investigated whether any changes in proliferating (BrdU and Ki67) or apoptotic (CC3) markers, detected upon treatment with TW4 serum samples, were able to predict later IFN-α–induced depression. Here, MKI67 is linked to depressive disorder.